Evaluation of a programming algorithm for deep brain stimulation in dystonia used in a double-blind, sham-controlled multicenter study

被引:5
|
作者
Steigerwald, Frank [1 ,2 ,8 ]
Kirsch, Anna Dalal [1 ]
Kuehn, Andrea [3 ]
Kupsch, Andreas [4 ]
Mueller, Joerg [5 ,6 ]
Eisner, Wilhelm [7 ]
Deuschl, Gunther [8 ]
Falk, Daniela [9 ]
Schnitzler, Alfons [10 ,11 ]
Skogseid, Inger Marie
Vollmer-Haase, Juliane
Ip, Chi
Tronnier, Volker
Vesper, Jan
Naumann, Markus [1 ]
Volkmann, Jens [1 ,8 ]
机构
[1] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany
[2] Rhon Klinikum, Dept Neurol & Neurol Crit Care, Bad Neustadt an der Saale, Germany
[3] Charite Univ Med Berlin, Dept Neurol, Campus Mitte, Berlin, Germany
[4] Movement Disorder Ctr Berlin, Neurol Moves, Berlin, Germany
[5] Vivantes Hosp Berlin Spandau, Dept Neurol, Berlin, Germany
[6] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[7] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria
[8] Univ Kiel, Dept Neurol, Kiel, Germany
[9] Univ Kiel, Dept Neurosurg, Kiel, Germany
[10] Heinrich Heine Univ, Dept Neurol, Dusseldorf, Germany
[11] Heinrich Heine Univ, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany
来源
NEUROLOGICAL RESEARCH AND PRACTICE | 2019年 / 1卷 / 01期
关键词
Deep brain stimulation; Programming algorithm; Dystonia; Pallidum; Long-term outcome; CLINICAL-EFFICACY; FOLLOW-UP;
D O I
10.1186/s42466-019-0032-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Programming deep brain stimulation in dystonia is difficult because of the delayed benefits and absence of evidence-based guidelines. Therefore, we evaluated the efficacy of a programming algorithm applied in a double-blind, sham-controlled multicenter study of pallidal deep brain stimulation in dystonia. Methods: A standardized monopolar review to identify the contact with the best acute antidystonic effect was applied in 40 patients, who were then programmed 0.5 V below the adverse effect threshold and maintained on these settings for at least 3 months, if tolerated. If no acute effects were observed, contact selection was based on adverse effects or anatomical criteria. Three-year follow-up data was available for 31 patients, and five-year data for 32 patients. The efficacy of the algorithm was based on changes in motor scores, adverse events, and the need for reprogramming. Results: The mean (+/- standard deviation) dystonia motor score decreased by 73 +/- 24% at 3 years and 63 +/- 38% at 5 years for contacts that exhibited acute improvement of dystonia (n = 17) during the monopolar review. Contacts without acute benefit improved by 58 +/- 30% at 3 years (n = 63) and 53 +/- 31% at 5 years (n = 59). Interestingly, acute worsening or induction of dystonia/dyskinesia (n = 9) correlated significantly with improvement after 3 years, but not 5 years. Conclusions: Monopolar review helped to detect the best therapeutic contact in approximately 30% of patients exhibiting acute modulation of dystonic symptoms. Acute improvement, as well as worsening of dystonia, predicted a good long-term outcome, while induction of phosphenes did not correlate with outcome.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson’s disease: a study protocol
    T. J. C. Zoon
    G. van Rooijen
    M. F. Contarino
    S. van der Gaag
    R. Zutt
    J. T. van Asseldonk
    P. van den Munckhof
    P. R. Schuurman
    D. A. J. P. Denys
    R. M. A. de Bie
    Trials, 25
  • [32] Quality of Life after Deep Brain Stimulation of Pediatric Patients With Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study With a Subsequent Randomized Double-Blind Crossover (STIM-CP)
    Koy, Anne
    Kuehn, Andrea A.
    Huebl, Julius
    Schneider, Gerd-Helge
    van Riesen, Anne K.
    Eckenweiler, Matthias
    Rensing-Zimmermann, Cornelia
    Coenen, Volker Arnd
    Krauss, Joachim K.
    Saryyeva, Assel
    Hartmann, Hans
    Haeussler, Martin
    Volkmann, Jens
    Matthies, Cordula
    Horn, Annette
    Schnitzler, Alfons
    Vesper, Jan
    Gharabaghi, Alireza
    Weiss, Daniel
    Bevot, Andrea
    Marks, Warren
    Pomykal, Angela
    Monbaliu, Elegast
    Borck, Guntram
    Mueller, Joerg
    Prinz-Langenohl, Reinhild
    Dembek, Till
    Visser-Vandewalle, Veerle
    Wirths, Jochen
    Schiller, Petra
    Hellmich, Martin
    Timmermann, Lars
    MOVEMENT DISORDERS, 2022, 37 (04) : 799 - 811
  • [33] A multicenter double-blind randomized crossover study comparing the impact of dorsal subthalamic nucleus deep brain stimulation versus standard care on apathy in Parkinson's disease: a study protocol
    Zoon, T. J. C.
    van Rooijen, G.
    Contarino, M. F.
    van der Gaag, S.
    Zutt, R.
    van Asseldonk, J. T.
    van den Munckhof, P.
    Schuurman, P. R.
    Denys, D. A. J. P.
    de Bie, R. M. A.
    TRIALS, 2024, 25 (01)
  • [34] Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
    Schnitzler, Alfons
    Mir, Pablo
    Brodsky, Matthew A.
    Verhagen, Leonard
    Groppa, Sergiu
    Alvarez, Ramiro
    Evans, Andrew
    Blazquez, Marta
    Nagel, Sean
    Pilitsis, Julie G.
    Poetter-Nerger, Monika
    Tse, Winona
    Almeida, Leonardo
    Tomycz, Nestor
    Jimenez-Shahed, Joohi
    Libionka, Witold
    Carrillo, Fatima
    Hartmann, Christian J.
    Groiss, Stefan Jun
    Glaser, Martin
    Defresne, Florence
    Karst, Edward
    Cheeran, Binith
    Vesper, Jan
    NEUROMODULATION, 2021,
  • [35] Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study
    Rashid-Lopez, Raul
    Macias-Garcia, Paloma
    Sanchez-Fernandez, F. Luis
    Cano-Cano, Fatima
    Sarrias-Arrabal, Esteban
    Sanmartino, Florencia
    Mendez-Bertolo, Constantino
    Lozano-Soto, Elena
    Gutierrez-Cortes, Remedios
    Gonzalez-Moraleda, Alvaro
    Forero, Lucia
    Lopez-Sosa, Fernando
    Zuazo, Amaya
    Gomez-Molinero, Rocio
    Gomez-Ramirez, Jaime
    Paz-Exposito, Jose
    Rubio-Esteban, Guillermo
    Espinosa-Rosso, Raul
    Cruz-Gomez, Alvaro J.
    Gonzalez-Rosa, Javier J.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [36] Thalamic Deep Brain Stimulation for Spasmodic Dysphonia: A Phase I Prospective Randomized Double-Blind Crossover Trial
    Honey, Christopher R.
    Krueger, Marie T.
    Almeida, Timoteo
    Rammage, Linda A.
    Tamber, Mandeep S.
    Morrison, Murray D.
    Poologaindran, Anujan
    Hu, Amanda
    NEUROSURGERY, 2021, 89 (01) : 45 - 52
  • [37] Penile low intensity shock wave treatment for PDE5I refractory erectile dysfunction: a randomized double-blind sham-controlled clinical trial
    Vinay, Jose
    Moreno, Daniel
    Rajmil, Osvaldo
    Ruiz-Castane, Eduard
    Sanchez-Curbelo, Josvany
    WORLD JOURNAL OF UROLOGY, 2021, 39 (06) : 2217 - 2222
  • [38] Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson's disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial
    Daniels, Christine
    Steigerwald, Frank
    Capetian, Philipp
    Matthies, Cordula
    Malzahn, Uwe
    Heuschmann, Peter U.
    Volkmann, Jens
    NEUROLOGICAL RESEARCH AND PRACTICE, 2020, 2 (01):
  • [39] Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson’s disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial
    Christine Daniels
    Frank Steigerwald
    Philipp Capetian
    Cordula Matthies
    Uwe Malzahn
    Peter U. Heuschmann
    Jens Volkmann
    Neurological Research and Practice, 2
  • [40] Active versus sham transcranial direct current stimulation (tDCS) as an adjunct to varenicline treatment for smoking cessation: Study protocol for a double-blind single dummy randomized controlled trial
    Zawertailo, Laurie
    Zhang, Helena
    Rahmani, Noreen
    Rajji, Tarek K.
    Selby, Peter
    PLOS ONE, 2022, 17 (12):